DURVALUMAB WITH PACLITAXEL/CARBOPLATIN plus BEVACIZUMAB THEN MAINTENANCE DURVALUMAB, BEVACIZUMAB plus OLAPARIB IN PATIENTS WITH NEWLY DIAGNOSED ADVANCED OVARIAN CANCER WITHOUT A TUMOUR BRCA1/2 MUTATION: RESULTS FROM THE DUO-O/ENGOT-OV46/AGO-OVAR 23/GOG-3025 TRIAL

被引：3

作者：

Marth, Christian ^{[1
,2
]}

Park-Simon, Tjoung-Won ^{[3
,4
]}

Aghajanian, Carol ^{[5
,6
]}

Reuss, Alexander ^{[7
]}

Nishio, Shin ^{[8
,9
]}

Lim, Myong Cheol ^{[10
,11
,12
]}

Rubio-Perez, Maria Jesus ^{[13
,14
]}

Vardar, Mehmet Ali ^{[15
,16
,17
]}

Scambia, Giovanni ^{[18
,19
]}

Sabatier, Renaud ^{[20
,21
]}

Haslund, Charlotte ^{[22
,23
]}

Colombo, Nicoletta ^{[24
,25
,26
]}

Chudecka-Glaz, Anita ^{[27
,28
]}

Lheureux, Stephanie ^{[29
,30
]}

Huygh, Greet ^{[31
,32
]}

Schochter, Fabienne ^{[33
,34
]}

Wenham, Robert M. ^{[35
,36
]}

Okamoto, Aikou ^{[37
,38
]}

Day, Emily ^{[39
]}

Harter, Philipp ^{[40
,41
]}

机构：

[1] Med Univ Innsbruck, Innsbruck, Austria

[2] AGO Au, Innsbruck, Austria

[3] Hannover Med Sch, Dept Gyncecol & Obstet, Hannover, Germany

[4] AGO, Hannover, Germany

[5] Mem Sloan Kettering Canc Ctr, New York, NY USA

[6] GOG F, New York, NY USA

[7] ENGOT, Marburg, Germany

[8] Kurume Univ, Dept Obstet & Gynecol, Sch Med, Kurume, Japan

[9] JGOG, Kurume, Japan

[10] Natl Canc Ctr, Dept Canc Control & Policy, Goyang, South Korea

[11] Natl Canc Ctr, Grad Sch Canc Sci & Policy, Goyang, South Korea

[12] KGOG, Goyang, South Korea

[13] Reina Sofia Univ Hosp, Cordoba, Spain

[14] GEICO, Cordoba, Spain

[15] Cukurova Univ, Fac Med, Dept Obstet & Gynecol, Adana, Turkiye

[16] Balcali Hosp, Dept Gynecol Oncol, Adana, Turkiye

[17] TRSGO, Adana, Turkiye

[18] Fdn Policlin Univ A Gemelli IRCCS, Rome, Italy

[19] MITO, Rome, Italy

[20] Aix Marseille Univ, CNRS, Inst Paoli Calmettes, Dept Med Oncol,CRCM,Inserm,Marseille Med Oncol De, Marseille, France

[21] GINECO, Marseille, France

[22] Aalborg Univ Hosp, Dept Oncol, Aalborg, Denmark

[23] NSGO, Aalborg, Denmark

[24] Univ Milano Bicocca, Milan, Italy

[25] Ist Europeo Oncol IRCCS, Milan, Italy

[26] MANGO, Milan, Italy

[27] Pomeranian Med Univ, Dept Gynecol Surg & Gynecol Oncol Adults & Adole, SPSK Nr 2, Szczecin, Poland

[28] PGOG, Szczecin, Poland

[29] Princess Margaret Hosp, Dept Med Oncol, Toronto, ON, Canada

[30] PMHC, Toronto, ON, Canada

[31] Onze Lieve Vrouwziekenhuis Aalst Campus Aalst Moo, Aalst, Belgium

[32] BGOG, Aalst, Belgium

[33] Univ Frauenklin Prittwitzstr, Ulm, Germany

[34] AGO, Ulm, Germany

[35] H Lee Moffitt Canc Ctr & Res Inst, Dept Gynecol Oncol, Tampa, FL USA

[36] GOG F, Tampa, FL USA

[37] Jikei Univ, Dept Obstet & Gynecol, Sch Med, Tokyo, Japan

[38] JGOG, Tokyo, Japan

[39] AstraZeneca, Oncol Biometr, Oncol RandD, Cambridge, England

[40] Kliniken Essen Mitte, Dept Gynecol & Gynecol Oncol, Essen, Germany

[41] AGO, Essen, Germany

来源：

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2023年 / 33卷

关键词：

D O I：

10.1136/ijgc-2023-ESGO.899

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1120

引用

页码：A428 / A429

页数：2